| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 26 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 06.09.2013 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181), haemagglutininum influenzae A (H3N2) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/Victoria/361/2011 (H3N2)-like: reassortant virus NYMC X-223A derived from A/Texas/50/2012), haemagglutininum influenzae B 15 µg et neuraminidasum inactivatum (Virus-Stamm B/Massachusetts/2/2012-like: reassortant virus NYMC BX-51B), kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0.1 µg, saccharum et formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 007 | Fertigspritze(n) à 0.5 ml | 9.10 | 18.65 | B | | Yes | | 008 | 10 1 Fertigspritze(n) à 0.5 ml | PR | PR | B | | Yes |
|
|
